.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
US Army
Harvard Business School
Deloitte
Medtronic
Cantor Fitzgerald
McKinsey
QuintilesIMS
Moodys
Merck

Generated: June 27, 2017

DrugPatentWatch Database Preview

Estrone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for estrone and what is the scope of estrone freedom to operate?

Estrone
is the generic ingredient in four branded drugs marketed by Watson Labs, Watson Labs Teva, Parkedale, and Wyeth Ayerst, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for estrone.

Summary for Generic Name: estrone

Tradenames:4
Patents:1
Applicants:4
NDAs:5
Drug Master File Entries: see list9
Bulk Api Vendors: see list62
Clinical Trials: see list35
Patent Applications: see list5,098
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:estrone at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Teva
ESTRONE
estrone
INJECTABLE;INJECTION085239-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Parkedale
THEELIN
estrone
INJECTABLE;INJECTION003977-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
NATURAL ESTROGENIC SUBSTANCE-ESTRONE
estrone
INJECTABLE;INJECTION085237-001Nov 23, 1982DISCNNoNo► Subscribe► Subscribe
Parkedale
THEELIN
estrone
INJECTABLE;INJECTION003977-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Wyeth Ayerst
ESTROGENIC SUBSTANCE
estrone
INJECTABLE;INJECTION083488-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Cipla
Daiichi Sankyo
Harvard Business School
Covington
Express Scripts
Teva
Mallinckrodt
Chinese Patent Office
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot